Fourteen-Day Gemcitabine-Docetaxel Chemotherapy Is Effective and Safer Compared to 21-Day Regimen in Patients with Advanced Soft Tissue and Bone Sarcoma

por Pan, Minggui, Trieu, Maily K., Sidhu, Manpreet, Yu, Jeanette, Seto, Tiffany, Ganjoo, Kristen
Publicado 2021

Real-World Experiences with Pazopanib in Patients with Advanced Soft Tissue and Bone Sarcoma in Northern California

por Seto, Tiffany, Song, Mee-Na, Trieu, Maily, Yu, Jeanette, Sidhu, Manpreet, Liu, Chi-Mei, Sam, Danny, Pan, Minggui
Publicado 2019